Necrotizing enterocolitis: A review of pathogenetic mechanisms and implications for prevention

Fetal and Pediatric Pathology

Volumn 13, Issue 3, 1993, Pages 357-369

  Caplan, Michael S ^a   Mackendrick, William ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

NEC; Necrotizing enterocolitis; PAF; Pathogenesis; Platelet activating factor; Premature newborns

Indexed keywords

APAFANT; IMMUNOGLOBULIN A; STEROID; THROMBOCYTE ACTIVATING FACTOR;

ANTIBIOTIC PROPHYLAXIS; BACTERIAL COLONIZATION; BREAST MILK; DISEASE SEVERITY; ENTERIC FEEDING; HUMAN; INCIDENCE; INTESTINE INJURY; INTESTINE ISCHEMIA; NECROTIZING ENTEROCOLITIS; NEWBORN; NEWBORN DEATH; PATHOGENESIS; PREMATURITY; REVIEW; TISSUE NECROSIS; UNITED STATES;

ENTEROCOLITIS, PSEUDOMEMBRANOUS; HUMAN; INFANT, NEWBORN;

EID: 0027301074     PISSN: 15513815     EISSN: None     Source Type: Journal    
DOI: 10.3109/15513819309048223     Document Type: Review

References (75)

1. Necrotizing enterocolitis
2. Necrotizing enterocolitis in very low birth weight infants: Biodemographic and clinical correlates
3. Neonatal necrotizing enterocolitis
4. Neonatal necrotizing enterocolitis
5. Necrotizing enterocolitis: Treatment based on staging criteria
6. Occult blood in stools and necrotizing enterocolitis: Is there a relationship?
7. Epidemiologic characteristics of necrotizing enterocolitis: A population-based study
8. Neonatal necrotizing enterocolitis: A nine-year expérience II. Outcome assessment
9. Colonie strictures following successful médical management of necrotizing enterocolitis: A prospective study evaluating early gastrointestinal contrast studies
10. Neonatal necrotizing enterocolitis: Survival, management, and complications: A 25 year study
11. Pathology of neonatal necrotizing enterocolitis: A ten-year expérience
12. Pathogenesis of enteritis necroticans in Papua New Guinea
13. Necrotizing enterocolitis in term infants
14. Necrotizing enterocolitis in full-term infants: A case-control study
15. Absent or reversed end dia-stolic flow velocity in the umbilical artery and necrotising enterocolitis
16. Myelomeningocele: A risk factor for necrotizing enterocolitis in term infants
17. Necrotizing enterocolitis in neonates with symptomatic congénital heart disease
18. The development of necrotizing enterocolitis following repair of gastroschisis: A surprisingly high incidence
19. Maternai cocaine abuse and necrotizing enterocolitis: Outcome and survival
20. Gastrointestinal host défense and necrotizing enterocolitis
21. Gut hormones and regulatory peptides in relation to enterai feeding, gastroenteritis, and necrotizing enterocolitis in infancy
22. Autoregulation in the developing postnatal intestinal circulation
23. Intestinal blood flow and 02 uptake during hypoxemia in the newborn piglet
24. Development of gastrointestinal mucosal bar-rier. I. The effect of age on intestinal permeability to macromolecules
25. Time of appearance of immunoglobulin-containing cells in the mucosa of the neonatal intestine
26. Neonatal necrotizing enterocolitis: A nine-year expérience. I. Epidemi-ology and uncommon observations
27. Preventing necrotizing enterocolitis in neonates
28. Expérimental production of necrotizing enterocolitis in newborn goats
29. Mucosal injury induced by ischemia and reperfusion in the piglet intestine: Influences of age and feeding
30. Pathogenesis of neonatal necrotising enterocolitis
31. Risk factors for necrotising enterocolitis: The influence of gestational age
32. Epidemiology of necrotizing enterocolitis: A case control study
33. The pathogenesis of ischémie gastroenterocolitis of the neonate: Sélective gut mucosal ischemia in asphyxiated neonatal piglets
34. Pathogenesis of early necrotizing enterocolitis in the hypoxic neonatal dog
35. Fine structural changes in the gastro-intestinal tract of the hypoxic puppy: A study of natural history
36. Ultrastructural changes in the canine ileal mucosal cell after mesenteric arterial occlusion: A sequential study
37. An expérimental study of acute neonatal enterocolitis—the importance of breast milk
38. Neonatal necrotizing enterocolitis: Implications for an infectious disease
39. A bactériologie basis for the clinical présentations of necrotizing enterocolitis
40. Quantitative changes in faecal microflora preceding necrotising enterocolitis in prématuré neonates
41. Epidémie occurrence of neonatal necrotizing enterocolitis
42. Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock
43. Spontaneous endotoxinemia in prématuré infants: Corrélations with oral feeding and bowel dysfunction
44. The pulmonary and systemic response to récurrent endotoxemia in the adult sheep
45. Is platelet activating factor (PAF) a mediator of endotoxin shock?
46. Shock and tissue injury induced by recombinant human cachectin
47. Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition
48. Bowel necrosis induced by tumor necrosis factor in rats is mediated by platelet-activating factor
49. Platelet activating factor: A biologically active phosphoglyceride
50. Platelet-activating factor and related acetylated lipids as potent biologically active cellular mediators
51. Human sérum acid-labile factor is an acyl-hydrolase that inactivates platelet-activating factor
52. Platelet activating factor (PAF) involvement in endotoxin-induced hypotension in rats. Studies with PAF-receptor antagonist kad-surenone
53. Expérimental model of ischémie bowel necrosis: The rôle of platelet-activating factor and endotoxin
54. Platelet activating factor is an endogenous mediator for bowel necrosis in endotoxemia
55. Platelet activating factor-induced ischémie bowel necrosis: The effect of PAF antagonists
56. Hypoxia causes ischémie bowel necrosis in rats: The rôle of platelet-activating factor (PAF-acether)
57. Endotoxin and hypoxia-induced intestinal necrosis in rats: The rôle of platelet activating factor
58. Rôle of platelet activating factor and tumor necrosis factor-alpha in neonatal necrotizing enterocolitis
59. Sérum PAF acetylhydrolase increases during neonatal maturation
60. Contamination of fermented milk products by proinflammatory autacoid PAF-acether
61. Breast milk and neonatal necrotising enterocolitis
62. A decreased incidence of necrotizing enterocolitis after prénatal glucocorticoid therapy
63. Prénatal and postnatal corticosteroid therapy to prevent neonatal necrotizing enterocolitis: A controlled trial
64. Oral vancomycin in prévention of necrotising enterocolitis
65. A prospective controlled trial of oral kanamycin in the prévention of neonatal necrotizing enterocolitis
66. Oral gentamicin therapy in the prévention of neonatal necrotizing enterocolitis. A controlled double-blind trial
67. Prévention of necrotizing enterocolitis in low-birth-weight infants by IgA-IgG feeding
68. Host résistance factors in human milk
69. Necrotizing enterocolitis in neonates fed human milk
70. Necrotizing enterocolitis and human milk
71. Synergistic effects of thyroxine and dexamethasone on enzyme ontogeny in rat small intestine
72. The effect of dexamethasone on the develop-ment of rat intestinal brush border enzymes in organ culture
73. Prévention of necrotizing enterocolitis in neonates at risk by oral-administration of monomeric IgG
74. Inhibition of ex-vivo PAF-induced platelet aggregation by the PAF-antagonist RP 48740: Relationship to plasma concentrations in healthy volunteers
75. Effect of a PAF antagonist, BN52063, on PAF-induced bronchoconstriction in normal subjects